Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s First Chief Scientist Is Wake Forest Oncologist Frank Torti

Executive Summary

FDA's new Chief Scientist Frank Torti will be asked to concentrate on clinical research when he assumes the newly created position in May, FDA announced April 9
Advertisement

Related Content

FDA’s Von Eschenbach Returns To Texas In January; Will He Also Return To MD Anderson?
FDA Chief Scientist Torti’s Plan For First 100 Days Centers On Excellence
FDA Chief Scientist Torti’s Plan For First 100 Days Centers On Excellence
FDA Commissioner Says Funding Imperils Agency Mission, Modernization
Woodcock Stays At CDER: Drug Center’s Gain Is FDA Science Program’s Loss
Vytorin trial receives House scrutiny
FDA Should Look Through IIRIS To Improve Science, Panel Says; Funding Is Worry
FDA Re-Org Makes Chief Of Staff Liaison Between Centers And Commissioner
FDA Reform Bill Leaves Senate With Reduced Safety Powers But Stiffer Fines
Advertisement
UsernamePublicRestriction

Register

PS049506

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel